Ver mas grande
VHL antibody
FT-FNab09402
Producto nuevo
100 µg
Comprando este producto generará 1 Biopunto. Su cesta contiene un total 1 Biopunto puede ser convertido en un Biobonos Descuento 4.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC, IF |
| Target | VHL |
| Research Area | Cancer, Metabolism |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | von Hippel-Lindau tumor suppressor |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | von Hippel-Lindau disease tumor suppressor|Protein G7|pVHL|VHL |
| Host | Rabbit |
| UniProt ID | P40337 |
| Gene ID | 7428 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 18-24 kDa |
| Background | Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as a target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor(HIF) |
Más información
VHL antibody